KELLI BURRESS: Open Payments
NPI 1912203894 · BAINBRIDGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$376 in 19 payments from 9 companies in 2025. Trend: 2023 $300 · 2024 $373 · 2025 $376
Food & beverage: $376
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $110 |
| ABBVIE INC. | 3 | $68 |
| PFIZER INC. | 2 | $45 |
| Viatris Specialty LLC | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
Products named: MOUNJARO, JARDIANCE, ELIQUIS, VRAYLAR, YUPELRI, UBRELVY, Wegovy, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
